Alpesh Patel's Archive

Alpesh Patel
Alpesh Patel

Alpesh Patel is an award-winning hedge fund and private equity fund manager, international bestselling author, entrepreneur and Dealmaker.

He is the Founder and CEO of Praefinium Partners and is a Financial Times Top FTSE 100 forecaster, beating leading fund managers, analysts and journalists.

He has penned more than 200 columns for the Financial Times and has written 18 book on investing, translated into six languages, including The Mind of a Trader and 7 Simple Strategies of Highly Effective Traders. (One of his books was even a top 5 bestseller on Amazon – right behind Harry Potter.) A frequent guest on financial news shows, Alpesh also hosted his own shows on Bloomberg TV, CNBC and Sky TV.

He’s a sought-after speaker, having presented at more than 500 conferences across the globe, including for Rothschilds, Goldman Sachs, Barclays, and the London Business School.

A University of Oxford alumnus and former Visiting Fellow in Business, Alpesh interned for U.S. Congressman Eliot Engel and was appointed to a U.K. advisory position by former Prime Minister Tony Blair.

As a senior-most Dealmaker in the U.K.’s Department for International Trade, he is part of a team that has helped deliver $1 billion of investment to the U.K. since 2005. He’s also a former Council Member of the 100-year-old Chatham House, the foreign affairs think-tank, whose patron is Queen Elizabeth. For his services to the U.K. economy, Alpesh received the Order of the British Empire (OBE) from the Queen in 2020.

As a recognized authority on fintech, online trading and venture capital, his past and current client list includes American Express, Merrill Lynch HSBC, Charles Schwab, Goldman Sachs, Barclays, NYSE Life… and more.

Alpesh is also known for his philanthropic efforts. He co-founded the U.K. chapter of the largest entrepreneur mentorship organization in the world (TIE.org), and is co-chair of the Loomba Foundation, which supports widows and orphans.

Investor Magazine calls him “The U.K.’s most respected stock picker.” The Independent says he is “An expert in his field.” And Channel 4 TV called him “UK’s best known online trader.”

Alpesh writes an elite weekly column for Total Wealth and runs the award-winning research service GVI Investor… bringing his hedge fund secrets to everyday investors.

Stock of the Week: A Contrarian Consumer Play for 2023

When the headlines are talking about one thing… it’s usually something else that’s making money. That’s why we’re looking at this consumer electronics play.


Stock of the Week: This Luxury Brand Is Designing Big Gains

It may seem odd to be looking at a luxury consumer discretionary stock… but this one will surprise you.


Stock of the Week: Big Gains From a Small Package

Wall Street is underestimating this packaging manufacturer. That means the gains could be big…


Stock of the Week: A Warning for This Soaring Semiconductor

This stock has been soaring since the pandemic began… but do its numbers line up with its price?


Stock of the Week: This Iconic Company Is Off to the Races

When you see Alpesh’s latest Stock of the Week, you may think he’s gone crazy. It’s nothing like the companies he’s shown you before. But here’s why he likes it…


Stock of the Week: Healthy Returns From a Soaring Pharma Company

Investors need resilient stocks when facing a recession. Alpesh has found a diverse pharma stock with double-digit growth ahead of it. See it in his latest video.


Stock of the Week: This Auto Tech Supplier Is in the Driver’s Seat

Business is booming at this leading global manufacturer of sensor integrated circuits.


Stock of the Week: Take a “Gamble” on This Contrarian Play

Alpesh has an unusual stock for readers this week. Despite recession fears and a higher cost of living, this stock with strong fundamentals is ready to break out.


Stock of the Week: This Company Is Game for Solid Growth

As the cost of living rises, this gaming and entertainment company benefits. And the numbers prove it.


Stock of the Week: More Reward, Less Risk With This Healthy Biotech

This biotech is looking to solve some of the world’s biggest medical problems. And the numbers show the stock has a great risk-reward profile. Check it out here…


BROUGHT TO YOU BY MANWARD PRESS